EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated CD39+T-Regulatory Cells and Reduced Levels of Adenosine Indicate a Role for Tolerogenic Signals in the Progression from Moderate to Severe COVID-19

Alaa Elsaghir iD, Ehsan M W El-Sabaa iD, Asmaa M Zahran, Sahar A Mandour iD, Eman H Salama, Sahar Aboulfotuh, Reham M El-Morshedy, Stefania Tocci, Ahmed Mohamed Mandour, Wael Esmat Ali, Lobna Abdel-Wahid, Ibrahim M Sayed iD und 1 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242417614 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Alaa Elsaghir und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology & Immunology, Faculty of Pharmacy, Assiut University, Assiut 71515, Egypt. Hauptthemen laut MEDLINE: Adenosine, COVID-19, T-Lymphocytes, Regulatory. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science, Technology & Innovation Funding Authority (STDF), Science, Technology & Innovation Funding Authority (STDF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viral infections trigger inflammation by controlling ATP release. CD39 ectoenzymes hydrolyze ATP/ADP to AMP, which is converted by CD73 into anti-inflammatory adenosine (ADO). ADO is an anti-inflammatory and immunosuppressant molecule which can enhance viral persistence and severity. The CD39-CD73-adenosine axis contributes to the immunosuppressive T-reg microenvironment and may affect COVID-19 disease progression. Here, we investigated the link between CD39 expression, mostly on T-regs, and levels of CD73, adenosine, and adenosine receptors with COVID-19 severity and progression. Our study included 73 hospitalized COVID-19 patients, of which 33 were moderately affected and 40 suffered from severe infection. A flow cytometric analysis was used to analyze the frequency of T-regulatory cells (T-regs), CD39+ T-regs, and CD39+CD4+ T-cells. Plasma concentrations of adenosine, IL-10, and TGF-β were quantified via an ELISA. An RT-qPCR was used to analyze the gene expression of CD73 and adenosine receptors (A1, A2A, A2B, and A3). T-reg cells were higher in COVID-19 patients compared to healthy controls (7.4 ± 0.79 vs. 2.4 ± 0.28; p < 0.0001). Patients also had a higher frequency of the CD39+ T-reg subset. In addition, patients who suffered from a severe form of the disease had higher CD39+ T-regs compared with moderately infected patients. CD39+CD4+ T cells were increased in patients compared to the control group. An analysis of serum adenosine levels showed a marked decrease in their levels in patients, particularly those suffering from severe illness. However, this was paralleled with a marked decline in the expression levels of CD73. IL-10 and TGF-β levels were higher in COVID-19; in addition, their values were also higher in the severe group. In conclusion, there are distinct immunological alterations in CD39+ lymphocyte subsets and a dysregulation in the adenosine signaling pathway in COVID-19 patients which may contribute to immune dysfunction and disease progression. Understanding these immunological alterations in the different immune cell subsets and adenosine signaling provides valuable insights into the pathogenesis of the disease and may contribute to the development of novel therapeutic approaches targeting specific immune mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenosineCOVID-19T-Lymphocytes, RegulatoryHumans5'-NucleotidaseAdenosine TriphosphateAnti-Inflammatory AgentsAntigens, CDDisease ProgressionInterleukin-10Receptors, Purinergic P1Transforming Growth Factor betaApyrase

Stichwörter der Autor:innen

ATPCD39CD73COVID-19T-regulatory cellsadenosine

Substanzen

5'-NucleotidaseAdenosineAdenosine TriphosphateAnti-Inflammatory AgentsAntigens, CDInterleukin-10Receptors, Purinergic P1Transforming Growth Factor betaCD39 antigenApyrase

Autor:innen und Institutionen

  • Department of Microbiology & Immunology, Faculty of Pharmacy, Assiut University, Assiut 71515, Egypt.
  • Department of Clinical Pathology, South Egypt Cancer Institute, Assiut University, Assiut 71515, Egypt.
  • Department of Microbiology and Immunology, Faculty of Pharmacy, Deraya University, Minia 11566, Egypt.
  • Department of Clinical Pathology, Faculty of Medicine, Sohag University, Sohag 82524, Egypt.
  • Department of Chest Diseases and Tuberculosis, Faculty of Medicine, Assiut University, Assiut 71515, Egypt.
  • Department of Biomedical & Nutritional Sciences, Zuckerberg College of Health Sciences, University of Massachusetts Lowell, Lowell, MA 01854, USA.

ORCID-Profile: Alaa Elsaghir, Ehsan M W El-Sabaa, Sahar A Mandour, Ibrahim M Sayed, Mohamed A El-Mokhtar

Förderung

  • Science, Technology & Innovation Funding Authority (STDF)
  • Science, Technology &amp; Innovation Funding Authority (STDF)

Zitieren

APA

Elsaghir, A., El-Sabaa, E. M. W., Zahran, A. M., Mandour, S. A., Salama, E. H., Aboulfotuh, S., El-Morshedy, R. M., Tocci, S., Mandour, A. M., Ali, W. E., Abdel-Wahid, L., Sayed, I. M., & El-Mokhtar, M. A. (2023). Elevated CD39+T-Regulatory Cells and Reduced Levels of Adenosine Indicate a Role for Tolerogenic Signals in the Progression from Moderate to Severe COVID-19. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242417614

Vancouver

Elsaghir A, El-Sabaa EMW, Zahran AM, Mandour SA, Salama EH, Aboulfotuh S, et al. Elevated CD39+T-Regulatory Cells and Reduced Levels of Adenosine Indicate a Role for Tolerogenic Signals in the Progression from Moderate to Severe COVID-19. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242417614

BibTeX
@article{Elsaghir2023,
  author = {Elsaghir, Alaa and El-Sabaa, Ehsan M W and Zahran, Asmaa M and Mandour, Sahar A and Salama, Eman H and Aboulfotuh, Sahar and El-Morshedy, Reham M and Tocci, Stefania and Mandour, Ahmed Mohamed and Ali, Wael Esmat and Abdel-Wahid, Lobna and Sayed, Ibrahim M and El-Mokhtar, Mohamed A},
  title = {Elevated CD39+T-Regulatory Cells and Reduced Levels of Adenosine Indicate a Role for Tolerogenic Signals in the Progression from Moderate to Severe COVID-19},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242417614}
}
Kostenlos starten →